ASPS study indicates breast reduction diminishes breast cancer in high-risk women

May 29, 2004

ARLINGTON HEIGHTS, Ill. - Women at high risk of developing breast cancer may have an additional preventative alternative to having their breasts removed - breast reduction surgery, according to a study published in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

Although the complete removal of a woman's breasts can diminish the chance of developing this potentially fatal disease, most women find it extremely difficult to elect to remove their breasts. Women may now have an additional preventative option, based on this report, to have their breasts reduced rather than removed. This represents a real alternative for someone who is a candidate for breast reduction, even though the amount of tissue removed may be small.

"Breast reduction is a risk reducer, not a preventative guarantee," said Leroy Young, MD, author of the study and chair of ASPS Emerging Trends Committee. "For the majority of women with a high inherited susceptibility to breast cancer, completely removing their breasts is not a desirable option as primary prevention. This study strongly indicates that women, who are breast reduction candidates, can choose to have their breasts reduced instead, thus decreasing their chance of developing breast cancer."

The report is based on six observational studies conducted in the United States, Canada, Denmark and Sweden. Collectively, the studies examined more than 32,000 women. It found that breast reduction lowered the chance of developing breast cancer 50 to 70 percent. Currently, clinical studies of high-risk women who elect to have their breasts completely removed, known as a prophylactic bilateral mastectomy, demonstrate that patients have lowered their risk by 90 percent. Because some residual breast tissue remains even after a total mastectomy, a 100 percent reduction in risk is not possible by mastectomy alone. These studies and patients in additional studies will continue.

An estimated 215,999 new invasive cases of breast cancer are expected to occur in 2004 among women in the United States, according to the American Cancer Society. This year, more than 40,000 women are expected to die from breast cancer.

"It's important that women understand their options. Having breast reduction surgery is better than what many high-risk women have done in the past because they did not want to lose their breasts - nothing," stated Dr. Young. "Educating women about breast reduction, which is often more acceptable than prophylactic mastectomy, could increase the number of women who elect risk-reduction surgery as a preventative measure, which could lead to an overall reduction in breast cancer mortality rates among high-risk women."

"While this report is based on observational studies, it's pretty clear that breast reduction could hold a key to decreasing breast cancer in high-risk patients. Undoubtedly, as we reduce the amount of breast tissue, we also reduce the risk of developing breast cancer," continued Dr. Young. "Going forward, we expect clinical studies will support our findings that breast reduction is a viable preventative alternative for many women."

More than 113,000 women had breast reduction surgery in 2003, according to ASPS statistics. Breast reconstruction was performed on more than 68,000 women in 2003, according to ASPS statistics.
For referrals to plastic surgeons certified by the American Board of Plastic Surgery and to learn more about cosmetic and reconstructive plastic surgery, call ASPS at 888-4-PLASTIC (888-475-2784) or visit

ASPS is the largest organization of board-certified plastic surgeons in the world and the foremost authority on cosmetic and reconstructive plastic surgery. With nearly 5,000 members, more than any other plastic surgery organization, ASPS is the definitive voice of the plastic surgery specialty. Viewed throughout the world as the pinnacle of information for new techniques, advances and plastic surgery trends, the society represents 94 percent of all the board-certified plastic surgeons in the U.S. Ninety-four percent of all ASPS members perform cosmetic plastic surgery and 89 percent of all ASPS members perform reconstructive plastic surgery. ASPS, founded in 1931, represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.

American Society of Plastic Surgeons

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to